Kevin J. Hellestrand

1.3k total citations
39 papers, 925 citations indexed

About

Kevin J. Hellestrand is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Physiology. According to data from OpenAlex, Kevin J. Hellestrand has authored 39 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 10 papers in Surgery and 2 papers in Physiology. Recurrent topics in Kevin J. Hellestrand's work include Cardiac Arrhythmias and Treatments (30 papers), Cardiac pacing and defibrillation studies (25 papers) and Cardiac electrophysiology and arrhythmias (23 papers). Kevin J. Hellestrand is often cited by papers focused on Cardiac Arrhythmias and Treatments (30 papers), Cardiac pacing and defibrillation studies (25 papers) and Cardiac electrophysiology and arrhythmias (23 papers). Kevin J. Hellestrand collaborates with scholars based in United Kingdom, Australia and Portugal. Kevin J. Hellestrand's co-authors include R. S. Bexton, A. John Camm, Anthony W. Nathan, A. W. Nathan, Roworth A.J. Spurrell, R A Spurrell, T A English, R Cory-Pearce, J R Milne and David Ward and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Kevin J. Hellestrand

37 papers receiving 843 citations

Peers

Kevin J. Hellestrand
Roworth A.J. Spurrell United Kingdom
Angas Hamer Australia
R A Spurrell United Kingdom
Bruce N. Goldreyer United States
Zakauddin Vera United States
Rodolphe Ruffy United States
Donald A. Chilson United States
William S. Frankl United States
Roworth A.J. Spurrell United Kingdom
Kevin J. Hellestrand
Citations per year, relative to Kevin J. Hellestrand Kevin J. Hellestrand (= 1×) peers Roworth A.J. Spurrell

Countries citing papers authored by Kevin J. Hellestrand

Since Specialization
Citations

This map shows the geographic impact of Kevin J. Hellestrand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin J. Hellestrand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin J. Hellestrand more than expected).

Fields of papers citing papers by Kevin J. Hellestrand

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin J. Hellestrand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin J. Hellestrand. The network helps show where Kevin J. Hellestrand may publish in the future.

Co-authorship network of co-authors of Kevin J. Hellestrand

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin J. Hellestrand. A scholar is included among the top collaborators of Kevin J. Hellestrand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin J. Hellestrand. Kevin J. Hellestrand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chia, Karin K.M., Logan Kanagaratnam, Kevin J. Hellestrand, Peter R. Kowey, & David Whalley. (2018). Pharmacological Therapy for Ventricular Arrhythmias: A State-of-the Art Review. Heart Lung and Circulation. 28(1). 49–56. 2 indexed citations
3.
Ooi, Sze‐Yuan, Suresh Singarayar, Kevin J. Hellestrand, et al.. (2017). BioMonitor 2 Pilot Study: Early Experience With Implantation of the Biotronik BioMonitor 2 Implantable Cardiac Monitor. Heart Lung and Circulation. 27(12). 1462–1466. 14 indexed citations
4.
Hellestrand, Kevin J.. (1996). Efficacy and safely of long-term oral flecamide acetate in patients with responsive supraventricular tachycardia. The American Journal of Cardiology. 77(3). 83A–88A. 10 indexed citations
5.
Hellestrand, Kevin J. & David Whalley. (1996). Radiofrequency catheter ablation of left ventricular tachycardia in the normal heart. Australian and New Zealand Journal of Medicine. 26(3). 380–385. 2 indexed citations
6.
Whalley, David & Kevin J. Hellestrand. (1990). Clinical benefit of transdermal glyceryl trinitrate when used with an eight hour patch‐free period. Australian and New Zealand Journal of Medicine. 20(5). 677–681. 3 indexed citations
7.
Hellestrand, Kevin J.. (1988). Intravenous flecainide acetate for supraventricular tachycardias. The American Journal of Cardiology. 62(6). 16–22. 30 indexed citations
8.
Nathan, A. W., Kevin J. Hellestrand, A. John Camm, & R. S. Bexton. (1987). Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias. Clinical Cardiology. 10(5). 317–322. 10 indexed citations
9.
Camm, A. John, Kevin J. Hellestrand, Anthony W. Nathan, & R. S. Bexton. (1985). Clinical Usefulness of Flecainide Acetate in the Treatment of Paroxysmal Supraventricular Arrhythmias. Drugs. 29(Supplement 4). 7–13. 21 indexed citations
10.
Bexton, R. S., Anthony W. Nathan, Kevin J. Hellestrand, et al.. (1984). Sinoatrial function after cardiac transplantation. Journal of the American College of Cardiology. 3(3). 712–723. 52 indexed citations
11.
Hellestrand, Kevin J., Anthony W. Nathan, R. S. Bexton, & A. John Camm. (1984). Response of an Abnormal Sinus Node to Intravenous Flecainide Acetate. Pacing and Clinical Electrophysiology. 7(3). 436–439. 6 indexed citations
12.
Bexton, R. S., Anthony W. Nathan, Kevin J. Hellestrand, et al.. (1984). The electrophysiologic characteristics of the transplanted human heart. American Heart Journal. 107(1). 1–7. 24 indexed citations
13.
Hellestrand, Kevin J., Anthony W. Nathan, R. S. Bexton, Roworth A.J. Spurrell, & A. John Camm. (1983). Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias. The American Journal of Cardiology. 51(5). 770–776. 65 indexed citations
14.
Bexton, R. S., Kevin J. Hellestrand, A. W. Nathan, R A Spurrell, & A. John Camm. (1983). A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia of oral and intravenous flecainide acetate. European Heart Journal. 4(2). 92–102. 34 indexed citations
15.
Bexton, R. S., A. W. Nathan, Kevin J. Hellestrand, et al.. (1983). Electrophysiological abnormalities in the transplanted human heart.. Heart. 50(6). 555–563. 28 indexed citations
16.
Spurrell, Roworth A.J., Anthony W. Nathan, R. S. Bexton, Kevin J. Hellestrand, & A. John Camm. (1982). A fully implantable pacemaker for automatic tachycardia termination — A clinical evaluation. The American Journal of Cardiology. 49(4). 1010–1010. 1 indexed citations
17.
Hellestrand, Kevin J., R. S. Bexton, A. W. Nathan, R A Spurrell, & A. John Camm. (1982). Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.. Heart. 48(2). 140–148. 116 indexed citations
18.
Nathan, A. W., A. John Camm, R. S. Bexton, Kevin J. Hellestrand, & R A Spurrell. (1982). Initial experience with a fully implantable, programmable, scanning, extrastimulus pacemaker for tachycardia termination. Clinical Cardiology. 5(1). 22–26. 17 indexed citations
19.
Nathan, Anthony W., Kevin J. Hellestrand, A. John Camm, & Roworth A.J. Spurrell. (1981). Automatic cycle length adjustment-a versatile pacemaker for tachycardia termination. The American Journal of Cardiology. 47. 476–476. 1 indexed citations
20.
Bauer, G. E., et al.. (1977). THE ASSESSMENT OF AN ANTIARRHYTHMIC AGENT, SUSTAINED‐RELEASE PROCAINAMIDE, WITH THE AID OF HOLTER MONITORING. The Medical Journal of Australia. 2(22). 733–735. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026